Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

7.08

+0.11 (1.58%)

At close: Aug 19, 2026, 4:00 PM EDT

7.04

-0.04 (-0.64%)

After-hours: Aug 19, 2026, 7:30 PM EDT

Harvard Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	87.81	86.55	94.14	112.25	113.34	118.9
Revenue Growth	-1.06%	-8.06%	-16.14%	-0.96%	-4.68%	16.46%
Gross Profit	51.07	49.91	54.81	66.39	62.29	67.65
Operating Income	1.97	1.5	-4.72	2.5	-5.19	3.69
Net Income	-10.41	-56.7	-12.41	-3.42	-9.52	-0.29
Earnings Per Share	-2.35	-12.80	-2.85	-0.81	-2.30	-0.10
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	38.79	38.97	41.74	48.21	49.91	49.83
Americas - Other	3.7	3.23	3.6	3.52	-	-
Europe, Middle East and Africa	27.35	26.71	28.41	33.28	-	-
China	11.67	10.97	13.3	18.49	16.39	13.5
Asia - Other	6.3	6.68	7.1	8.77	-	-
Total	87.81	86.55	94.14	112.25	113.34	118.9

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	6.5	8.61	4.11	7.78	4.51	7.82
Total Debt	44.21	44.28	44.59	42.97	54.24	56.96
Net Cash (Debt)	-37.7	-35.66	-40.49	-35.19	-49.73	-49.14
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.43	-8.03	-9.30	-8.30	-12.01	-12.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	0.65	6.73	1.44	14.03	1.15	1.26
Capital Expenditures	-1.77	-1.26	-2.64	-1.79	-1.59	-1.2
Free Cash Flow	-1.12	5.47	-1.2	12.24	-0.44	0.07
Free Cash Flow Growth	-	-	-	-	-	-99.18%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.16%	57.67%	58.22%	59.15%	54.96%	56.90%
Operating Margin	2.25%	1.73%	-5.01%	2.22%	-4.58%	3.10%
Pretax Margin	-12.00%	-66.30%	-12.39%	-2.28%	-8.10%	-0.12%
Profit Margin	-11.86%	-65.51%	-13.18%	-3.04%	-8.40%	-0.24%
FCF Margin	-1.27%	6.32%	-1.28%	10.90%	-0.39%	0.06%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	39.33	7.87	17.58	23.26	17.87	22.03
P/FCF Ratio	-	5.45	-	18.66	-	4294.24
PS Ratio	0.37	0.34	0.98	2.04	1.02	2.42